Duck embryonic derived stem cell lines for the production of viral vaccines
AssigneeValneva SE
InventorsFabienne Guehenneux, Karine Moreau, Magali Esnault, Majid Mehtali
Life of this patent
Estimating the term…
Abstract
The present invention relates to the development and manufacturing of viral vaccines. In particular, the invention relates to the field of industrial production of viral vectors and vaccines, more in particular to the use of avian embryonic stem cells, preferably the EBx® cell line derived from duck embryonic stem cells, for the production of viral vectors and viruses. The invention is particularly useful for the industrial production of viral vaccines to prevent viral infection of humans and animals.
Claims20
-23. (canceled)
A process of production of a virus which comprises replicating a virus in cells of an avian cell line wherein said cell line has been obtained by a method comprising the following steps:
- a) isolating a duck embryo around oviposition;
- b) dissociating the embryo of step a) into cells;
- c) seeding the dissociated cells of step b) in basal medium comprising insulin like growth factor 1 (IGF-1), ciliary neurotrophic factor (CNTF), animal serum, and a layer of feeder cells;
- d) culturing the cells of step c) for at least one passage;
- e) withdrawing the IGF-1 and CNTF from the culture of step d);
- f) culturing the cells of step e) for at least one passage;
- g) progressively withdrawing the feeder cells from the culture of step f);
- h) culturing the cells of step g) for at least one passage;
- i) progressively withdrawing the animal serum from the culture medium of step h) over several passages;
- and
- j) adapting the cells of step i) to suspension culture conditions such that a duck cell line capable of proliferating in basal medium in the absence of exogenous growth factors, a feeder layer, and animal serum is obtained, wherein the duck cell line does not produce replication-competent endogenous retrovirus particles;
- said process of production of virus comprising the steps of:
- 1) proliferating said cells in suspension, in a serum-free medium;
- 2) infecting the cells with said virus;
- 3) culturing said infected cells in order to allow virus replication;
- and
- 4) harvesting said virus.
Dependencies are inferred from the claim text.